November 2018 – Paolo Magri, Senior VP Business Development at Advitech as President of DCAT Board of Directors.

We are very pleased to announce that Paolo Magri, Senior Vice President, Business Development at Advitech SA, has been elected to serve as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2018.

Under Mr. Magri’s leadership, the Board will develop and guide the organization’s strategic plan in a manner to best serve the organization’s 500+ member companies.

DCAT’s Board of Directors is also tasked with developing strategies for the organization’s flagship event, DCAT Week. Held annually in March in New York City, DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. 92% of DCAT Week attendees are high-level decision makers from around the world who come together for business development meetings, networking opportunities and education programs.

“We are pleased to have Mr. Magri as our Board President,” said DCAT Executive Director Margaret Timony. “We rely on board members to bring innovative ideas and strategies to the table so we can continue to give our members relevant, valuable experiences across all that we offer. Mr. Magri’s passion for DCAT will undoubtedly continue to make a positive impact on our organization.”
“Mr. Magri is a longtime DCAT volunteer and brings a wealth of industry expertise and energy to the organization,” said Joe Sutton, Global Director of Sourcing for Eli Lilly and Company and DCAT’s out-going Board President. “We are fortunate to have Mr. Magri’s leadership and support as we shape our strategic plan to continue to deliver value to our member companies.”

Lugano, 1 November 2018

close

September 2018 – Advitech joined Farma Industria Ticino (FIT) as member.

Advitech has become member of Farma Industria Ticino (FIT) last September 2018. Farma Industria Ticino, a private organization founded in 1980, is the association of chemical and pharmaceutical industries in the Swiss canton of Ticino, headquartered in Lugano.

FIT represents the greatest majority of Ticino-based companies of this specific sector.
www.farmaindustriaticino.ch

close

December 2018 – Advitech’s new project : APIsTRENDS – a collection of reports.

Advitech has just launched its new project : APIsTRENDS, a collection of reports focused on the active pharmaceutical ingredients (APIs) world, to offer an original contribution to the APIs Business Community, comprising APIs producers, clients, investors and shareholders.

The first issue of the APIsTRENDS collection ,CDMO Benchmarking Report – Baseline analysis, is now available at apistrends.advitechswiss.com to provide a benchmarking study for the CDMO sector , starting with a baseline analysis referred to 2016 data.

close

December 2018 – Advitech’s charity support activities .

Advitech this year supported:

ARGHOSHA FARAWAY SCHOOLS
bringing education in the remotest areas of Afghanistan since 2005
www.arghosha.org

FONDAZIONE PIME ONLUS
a missionary center since 1850 focused on international cooperations, adoptions and humanitarians actions as primary care in rural areas in Bangladesh
www.pimemilano.com

close

November/December 2018 – Contract Pharma .

Pharma future : Trends to Watch
DCAT President discusses evolving pharma product mix and industry implications.
Read Article

close

December 2018/January 2019 – Speciality Chemicals Magazine.

In every challenge lies opportunity
Paolo Magri’, Senior Vice President Business Development at Advitech Advisory and Technologies and President of the Drug, Chemical and Associated Technologies Association (DCAT), shares his thoughts on the challenges and opportunities facing the pharmaceutical industry and related trends in drug development and manufacturing.
Read Article

close

January/February 2019 – Chemistry Today.

A word with Paolo Magri’ – President at DCAT (Drug, Chemical and Associated Technologies Association)
Paolo Magri’ shared his thoughts on trends in the fine-chemicals sector, including specialized manufacturing technologies and the future of a one-stop-shop business model with Chemistry Today.
Read Article

close

May 22nd 2019 – Corriere del Ticino.

FIT Farma Industria Ticino General Assembly Meeting in Lugano.
FIT Farma Industria Ticino (the association of chemical and pharmaceutical industries in the Swiss canton of Ticino) General Assembly Meeting in Lugano. A strong growth of the pharmaceutical industry in the Ticino economy.
Read Article

close

November 2019 – Advitech at CPhI worldwide 2019 in Frankfurt.

6 November PHARMA INSIGHT BRIEFINGS

Advitech shared its new project CDMO Benchmarking Report – A trend analysis 2016/2018 with all contacts and friends at CPhI WW 2019.
Thanks to all the attendees for the interest and support.

Please click here If you want to see the Advitech presentation

close

close

November 1, 2019 – Advitech SA Business Development Executive Elected as President of Board of Directors of the Drug, Chemical & Associated Technologies Association.

Robbinsville, NJ – Paolo Magri, Senior Vice President, Business Development at Advitech SA, has been elected to serve for a second term as President of the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2019. Under Mr. Magri’s continued leadership, the board will develop and guide the organization’s strategic plan in a manner to best serve the organization’s 500+ member companies.

“We are pleased that Mr. Magri will be returning as Board President for a second term,” said DCAT Executive Director Margaret Timony. “His continued service will have a positive impact on the organization by providing for continuity in leadership as we endeavor to pursue the goals of our strategic plan.”

DCAT’s Board of Directors is also tasked with developing strategies for the organization’s flagship event, DCAT Week. Held annually in March in New York City, DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. Ninety-two percent of DCAT Week attendees are high-level decision makers from around the world who come together for business development meetings, networking opportunities and education programs.

“The DCAT organization had a very successful year under the leadership of Mr. Magri. As a longtime DCAT volunteer, he brings a clear understanding of the goals of the organization and its member companies,” said Joe Sutton, Global Director of Sourcing for Eli Lilly and Company and DCAT’s Immediate Past President. “We are very fortunate to have Mr. Magri’s leadership and support for a second term as Board President as we shape our strategic plan to continue to deliver value to our member companies.”

For more information about DCAT’s Board of Directors, please visit https://dcat.org/BoardofDirectors.htm

close

January 2020 – CDMO Benchmarking Report a three-year update.

The CDMO rise is a key aspect of the pharmaceutical industry’s evolution, where two-thirds of pharmaceutical manufacturing is outsourced and Advitech has identified the major trends impacting this sector, with a specific focus on small molecules.

Advitech has now combined the previous CDMO Benchmarking Report – Baseline Analysis with the latest data and we are able to outline a three-year trend update, CDMO Benchmarking Report -A trend analysis 2016 – 2018 , an unprecedented approach in this industrial sector now available on apistrends.advitechswiss.com

close